|
24002
|
Anti-gliadine DP IgG
Gedeamideerde gliadine IgG
|
|
Serum |
Maandag t/m vrijdag |
7 (0,3) |
–
|
58710-5
U/ml |
20496-6
U/ml |
› |
|
3306
|
anti-glycine receptor As
✉
|
|
Serum |
|
319 (13,3) |
–
|
95722-5
|
—
|
› |
|
24496
|
anti-HBs na 4 weken
HBV surface antistoffen na 4 weken
|
|
Serum |
Dagelijks |
1 (0) |
B
|
—
mIU/mL |
—
|
› |
|
24499
|
anti-HBs na booster
HBV surface antistoffen na booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
24506
|
anti-HBs na booster 5
|
|
Serum |
|
1 (0) |
–
|
—
mIU/mL |
—
|
› |
|
24497
|
anti-HBs voor booster
HBV surface antistoffen voor booster
|
|
Serum |
|
1 (0,1) |
B
|
—
mIU/mL |
—
|
› |
|
3314
|
Anti-histonen
✉
|
|
Serum |
|
|
–
|
17380-7
U/ml |
—
|
› |
|
2592
|
anti-IA2 antilichamen
✉
|
|
Serum |
Maandelijks |
909 (37,9) |
–
|
31209-0
U/mL |
—
|
› |
|
23206
|
Anti-intrinsic factor IgG
Anti-intrisic factor antistoffen, Intrisic factor antistoffen
|
|
Serum |
Maandag t/m vrijdag |
34 (1,4) |
–
|
56539-0
U/mL |
—
|
› |
|
3242
|
anti-MAG As
✉
Myeline geassocieerde glycoproteïne antistoffen
|
|
Serum |
|
873 (36,4) |
–
|
31023-5
|
—
|
› |
|
24611
|
Anti-Mazelen IgG
|
|
Serum |
3x per week |
58 (2,4) |
B
|
7962-4
IU/L |
7962-4
mIU/mL |
› |
|
23354
|
Anti-MOG (1/1)
Myeline oligodentrocyte glycoproteïne antistoffen (1/1)
|
|
Lumbaalvocht (CSV) |
1x per 1-2 weken |
112 (4,7) |
–
|
91543-9
|
—
|
› |
|
23304
|
Anti-MOG (1/10)
Myeline oligodentrocyte glycoproteïne antistoffen (1/10)
|
|
Serum |
1x per 1-2 weken |
46 (1,9) |
–
|
106548-1
|
—
|
› |
|
23353
|
Anti-MOG titer
|
|
Serum |
|
149 (6,2) |
–
|
84873-9
|
—
|
› |
|
23355
|
Anti-MOG titer
|
|
Lumbaalvocht (CSV) |
|
|
–
|
—
|
—
|
› |
|
25054
|
Anti-Müllerian Hormoon
|
|
Serum |
Dagelijks |
23 (1) |
B
|
38476-8
ng/mL |
—
|
› |
|
3277
|
anti-MuSK As
✉
Anti-muscle specific kinase antistoffen
|
|
Serum |
|
278 (11,6) |
–
|
94273-0
|
—
|
› |
|
3313
|
Anti-nucleosomen
✉
|
|
Serum |
|
|
–
|
53014-7
U/ml |
—
|
› |
|
24185
|
Anti-Tetanus Toxoid IgG
|
|
Serum |
1x per week |
177 (7,4) |
–
|
—
IU/mL |
—
|
› |
|
24948
|
Anti-thyroglobuline As
Anti-TG antistoffen, Colloïd antistoffen, Thyreoglobuline antistoffen
|
|
Serum |
Maandag t/m vrijdag |
5 (0,2) |
B
|
8098-6
IU/mL |
—
|
› |
|
24952
|
Anti-TPO As
|
|
Serum |
Maandag t/m vrijdag |
|
–
|
8099-4
IU/mL |
—
|
› |
|
24016
|
Anti-transglutaminase IgA
anti-transglutaminase IgA, Tissue Transglutaminase IgA, tTG IgA
|
|
Serum |
Maandag t/m vrijdag |
10 (0,4) |
–
|
31017-7
U/ml |
46128-5
U/ml |
› |
|
24017
|
Anti-transglutaminase IgG
anti-transglutaminase IgG, Tissue Transglutaminase IgG, tTG IgG
|
|
Serum |
Maandag t/m vrijdag |
7 (0,3) |
–
|
32998-7
U/ml |
56537-4
U/ml |
› |
|
3316
|
anti-VGCC (Ca kanaal As)
✉
|
|
Serum |
|
412 (17,2) |
–
|
31024-3
pmol/L |
—
|
› |
|
1344
|
Anti-Xa Apixaban
✉
|
|
Citraat |
Dagelijks |
18 (0,7) |
–
|
74214-8
ng/mL |
—
|
› |
|
1343
|
anti-Xa Rivaroxaban
✉
Anti-Xa (New Oral AntiCoagulants)
|
|
Citraat |
1x per week |
|
–
|
74871-5
ng/mL |
—
|
› |
|
4484
|
anti Delta As
✉
Hepatitis D virus As
|
|
Serum |
|
312 (13) |
–
|
95141-8
|
—
|
› |
|
69860
|
AntiD fRhD genotypering
Panel
|
|
EDTA |
|
289 (12) |
–
|
—
|
—
|
› |
|
8298
|
Antidepress.opsporen/id.
✉
|
|
Urine |
|
381 (15,9) |
–
|
19312-8
|
—
|
› |
|
27197
|
Antidiuretisch hormoon
Panel
ADH, Vasopressine
|
|
24-uurs urinecollectie |
|
320 (13,3) |
–
|
—
|
—
|
› |
|
25242
|
Antidiuretisch hormoon
ADH, Vasopressine
|
|
EDTA |
1x per 3-4 weken |
398 (16,6) |
–
|
3126-0
pg/ml |
3126-0
ng/l |
› |
|
56205
|
Antimoon (volbloed)
Sb
|
|
Oligo-elementen (spoorelementen) |
Tenminste 2x per week |
|
–
|
5578-0
µg/l |
50809-3
nmol/L |
› |
|
57490
|
Antimoon /g creatinine
Panel
Sb
|
|
Urine |
|
226 (9,4) |
–
|
—
|
—
|
› |
|
23236
|
Antineutr.cytopl.As(ANCA)
ANCA, Anti-cytoplasmatische antistoffen
|
|
Serum |
Maandag t/m vrijdag |
76 (3,2) |
–
|
35279-9
|
—
|
› |
|
1313
|
Antithrombine (dier)
✉
|
|
Citraat |
Maandag t/m vrijdag |
67 (2,8) |
–
|
—
% |
—
|
› |
|
21310
|
Antitrombine
ATIII
|
|
Citraat |
2x per week (voorzien op Dinsdag en Vrijdag) |
90 (3,8) |
–
|
27811-9
% |
—
|
› |
|
21339
|
APC resistentie
APC resistentie
|
|
Citraat |
2x per week (voorzien op Dinsdag en Vrijdag) |
95 (4) |
–
|
48591-2
|
—
|
› |
|
22280
|
APO A1 - APO B
Panel
Apo B/A1 ratio
|
|
Serum |
|
45 (1,9) |
–
|
1874-7
|
—
|
› |
|
22283
|
Apolipoproteine A1
Apo A1
|
|
Serum |
Maandag t/m vrijdag |
23 (1) |
–
|
1869-7
g/L |
—
|
› |
|
22285
|
Apolipoproteine B
Apo B
|
|
Serum |
Maandag t/m vrijdag |
25 (1) |
–
|
1884-6
g/L |
—
|
› |
|
8522
|
Appaloosa patroon 1
✉
|
|
EDTA |
|
|
–
|
—
|
—
|
› |
|
71049
|
Appel f49 IgG
|
|
Serum |
2x per week, op Dinsdag en Vrijdag |
|
–
|
—
mgA/l |
—
|
› |
|
21220
|
APTT
APTT
|
|
Citraat |
Dagelijks |
2 (0,1) |
B
|
14979-9
sec |
3173-2
sec |
› |
|
21222
|
APTT
|
|
Citraat |
|
2 (0,1) |
–
|
—
sec |
—
|
› |
|
8452
|
AR congenitale ichtiose
✉
|
|
EDTA |
1x per 3 weken |
|
–
|
—
|
—
|
› |
|
5608
|
Aripiprazol
✉
Abilify
|
|
Serum |
1x per 1-2 weken |
216 (9) |
–
|
74931-7
µg/L |
—
|
› |
|
5613
|
Aripiprazol/dehydroapipr.
Panel
|
|
Serum |
|
232 (9,7) |
–
|
—
|
—
|
› |
|
56120
|
Arseen (plasma)
As
|
|
Oligo-elementen (spoorelementen) |
2x per week |
164 (6,8) |
B
|
5585-5
µg/L |
25323-7
µmol/L |
› |
|
56121
|
Arseen (volbloed)
|
|
Oligo-elementen (spoorelementen) |
Tenminste 2x per week |
122 (5,1) |
B
|
5583-0
µg/l |
15114-2
nmol/L |
› |
|
57563
|
As speciatie in urine
Panel
As speciatie in urine
|
|
Urine |
|
164 (6,8) |
–
|
18406-9
|
—
|
› |
